메뉴 건너뛰기




Volumn 42, Issue 6, 1998, Pages 1309-1314

Treatment of infection due to Pneumocystis carinii

Author keywords

[No Author keywords available]

Indexed keywords

8 AMINOQUINOLINE DERIVATIVE; ANTIBIOTIC AGENT; ATOVAQUONE; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DAPSONE; EFLORNITHINE; FANSIDAR; FOLINIC ACID; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MACROLIDE; PENTAMIDINE ISETHIONATE; PIRITREXIM; PREDNISONE; PRIMAQUINE; PYRIMETHAMINE; SULFADIAZINE; SULFONAMIDE; TRIMETREXATE;

EID: 0031835364     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.6.1309     Document Type: Short Survey
Times cited : (91)

References (61)
  • 3
    • 19244363256 scopus 로고    scopus 로고
    • Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia
    • Barber, B. A., P. S. Pegram, and K. P. High. 1996. Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia. Clin. Infect. Dis. 23: 718-722.
    • (1996) Clin. Infect. Dis. , vol.23 , pp. 718-722
    • Barber, B.A.1    Pegram, P.S.2    High, K.P.3
  • 5
    • 0028851780 scopus 로고
    • Evaluation of potent inhibitors of dihydrofolate reductase in a culture model for growth of Pneumocystis carinii
    • Bartlett, M. S., M. M. Shaw, P. Navaran, J. W. Smith, and S. F. Queener. 1995. Evaluation of potent inhibitors of dihydrofolate reductase in a culture model for growth of Pneumocystis carinii. Antimicrob. Agents Chemother. 39:2436-2441.
    • (1995) Antimicrob. Agents Chemother. , vol.39 , pp. 2436-2441
    • Bartlett, M.S.1    Shaw, M.M.2    Navaran, P.3    Smith, J.W.4    Queener, S.F.5
  • 7
    • 0026072156 scopus 로고
    • Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon
    • Beck, J. M., H. D. Liggitt, E. N. Brunette, H. J. Fuchs, J. E. Shellito, and R. J. Debs. 1991. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect. Immun. 59:3859-3862.
    • (1991) Infect. Immun. , vol.59 , pp. 3859-3862
    • Beck, J.M.1    Liggitt, H.D.2    Brunette, E.N.3    Fuchs, H.J.4    Shellito, J.E.5    Debs, R.J.6
  • 8
    • 0028348331 scopus 로고
    • Disseminated cryptococcal disease complicating steroid therapy for Pneumocystis carinii pneumonia in a patient with AIDS
    • Bernstein, B., P. Flomenberg, and D. Letzer. 1987. Disseminated cryptococcal disease complicating steroid therapy for Pneumocystis carinii pneumonia in a patient with AIDS. South. Med. J. 87:537-538.
    • (1987) South. Med. J. , vol.87 , pp. 537-538
    • Bernstein, B.1    Flomenberg, P.2    Letzer, D.3
  • 9
    • 0028335216 scopus 로고
    • Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS (ACTG 044)
    • Black, J. R., J. Feinberg, R. L. Murphy, R. J. Fass, D. Finkelstein, and B. Akil. 1994. Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS (ACTG 044). Clin. Infect. Dis. 18:905-913.
    • (1994) Clin. Infect. Dis. , vol.18 , pp. 905-913
    • Black, J.R.1    Feinberg, J.2    Murphy, R.L.3    Fass, R.J.4    Finkelstein, D.5    Akil, B.6
  • 13
    • 0028204471 scopus 로고
    • Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia
    • Caumes, E., C. Roudier, O. Rogeaux, F. Bricaire, and M. Gentilini. 1994. Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia. Clin. Infect. Dis. 18:319-323.
    • (1994) Clin. Infect. Dis. , vol.18 , pp. 319-323
    • Caumes, E.1    Roudier, C.2    Rogeaux, O.3    Bricaire, F.4    Gentilini, M.5
  • 14
    • 0029562294 scopus 로고
    • Intrapulmonary and systemic pharmacokinetics of aerosolized pentamidine used for prophylaxis of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus
    • Conte, J. E., Jr., and J. A. Golden. 1995. Intrapulmonary and systemic pharmacokinetics of aerosolized pentamidine used for prophylaxis of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. J. Clin. Pharmacol. 35:1166-1173.
    • (1995) J. Clin. Pharmacol. , vol.35 , pp. 1166-1173
    • Conte J.E., Jr.1    Golden, J.A.2
  • 15
    • 0025293183 scopus 로고
    • Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial
    • Conte, J. E., Jr., D. Chernoff, D. W. Feigal, Jr., P. Joseph, C. McDonald, and J. A. Golden. 1990. Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial. Ann. Intern. Med. 113:203-209.
    • (1990) Ann. Intern. Med. , vol.113 , pp. 203-209
    • Conte J.E., Jr.1    Chernoff, D.2    Feigal D.W., Jr.3    Joseph, P.4    McDonald, C.5    Golden, J.A.6
  • 18
    • 0028025544 scopus 로고
    • Selective inhibition of topoisomerases from Pneumocystis carinii compared with that of mammalian cells
    • Dykstra, C. C., D. R. McClernon, L. P. Elwell, and R. R. Tidwell. 1994. Selective inhibition of topoisomerases from Pneumocystis carinii compared with that of mammalian cells. Antimicrob. Agents Chemother. 38:1890-1898.
    • (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 1890-1898
    • Dykstra, C.C.1    McClernon, D.R.2    Elwell, L.P.3    Tidwell, R.R.4
  • 19
    • 0029652322 scopus 로고
    • Case records of the Massachusetts General Hospital
    • Fishman, J. A. 1995. Case records of the Massachusetts General Hospital. N. Engl. J. Med. 332:249-258.
    • (1995) N. Engl. J. Med. , vol.332 , pp. 249-258
    • Fishman, J.A.1
  • 20
    • 0031959697 scopus 로고    scopus 로고
    • Prevention of infection due to Pneumocystis carinii
    • 19a. Fishman, J. A. 1998. Prevention of infection due to Pneumocystis carinii. Antimicrob. Agents Chemother. 42:995-1004.
    • (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 995-1004
    • Fishman, J.A.1
  • 21
    • 0027235455 scopus 로고
    • Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model
    • Fishman, J. A., S. F. Queener, R. S. Roth, and M. S. Bartlett. 1993. Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model. Antimicrob. Agents Chemother. 37:1543-1546.
    • (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 1543-1546
    • Fishman, J.A.1    Queener, S.F.2    Roth, R.S.3    Bartlett, M.S.4
  • 22
    • 0025144705 scopus 로고
    • Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: A double blind, placebo controlled trial
    • Gagnon, S., A. M. Boota, M. A. Fischl, H. Baier, O. W. Kirksey, and L. LaVoie. 1990. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a double blind, placebo controlled trial. N. Engl. J. Med. 323:1444-1450.
    • (1990) N. Engl. J. Med. , vol.323 , pp. 1444-1450
    • Gagnon, S.1    Boota, A.M.2    Fischl, M.A.3    Baier, H.4    Kirksey, O.W.5    Lavoie, L.6
  • 23
    • 0030899403 scopus 로고    scopus 로고
    • Neutralization of interferon-gamma exacerbates pneumocystis driven interstitial pneumonitis following bone marrow transplantation in mice
    • Garvy, B. A., F. Gigliotti, and A. G. Harmsen. 1997. Neutralization of interferon-gamma exacerbates pneumocystis driven interstitial pneumonitis following bone marrow transplantation in mice. J. Clin. Invest. 99:1637-1644.
    • (1997) J. Clin. Invest. , vol.99 , pp. 1637-1644
    • Garvy, B.A.1    Gigliotti, F.2    Harmsen, A.G.3
  • 24
    • 0026729844 scopus 로고
    • Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia
    • Hoffman, A., M. Lawrence, F. Ognibene, A. Suffredini, G. Lipschik, J. Kovacs, H. Masur, and J. Shelhamer. 1992. Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia. Chest 102:1730-1736.
    • (1992) Chest , vol.102 , pp. 1730-1736
    • Hoffman, A.1    Lawrence, M.2    Ognibene, F.3    Suffredini, A.4    Lipschik, G.5    Kovacs, J.6    Masur, H.7    Shelhamer, J.8
  • 25
    • 0027178290 scopus 로고
    • Anti-Pneumocystis carinii activity of PS-15, a new higuanide folate antagonist
    • Hughes, W., D. Jacobus, C. Canfield, and J. Killmar. 1993. Anti-Pneumocystis carinii activity of PS-15, a new higuanide folate antagonist. Antimicrob. Agents Chemother. 37:1417-1419.
    • (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 1417-1419
    • Hughes, W.1    Jacobus, D.2    Canfield, C.3    Killmar, J.4
  • 26
    • 0029868005 scopus 로고    scopus 로고
    • Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia
    • Hughes, W., and J. Killmar. 1996. Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 40:962-965.
    • (1996) Antimicrob. Agents Chemother. , vol.40 , pp. 962-965
    • Hughes, W.1    Killmar, J.2
  • 27
    • 0028040787 scopus 로고
    • Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model
    • Hughes, W., J. Killmar, and H. Oz. 1994. Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model. J. Infect. Dis. 170: 906-911.
    • (1994) J. Infect. Dis. , vol.170 , pp. 906-911
    • Hughes, W.1    Killmar, J.2    Oz, H.3
  • 29
    • 0017834176 scopus 로고
    • Comparison of pentamidine isethionate and trimethoprimsulfamethoxazole in the treatment of Pneumocystis carinii pneumonia
    • Hughes, W. T., S. Feldman, S. C. Chaudhary, M. J. Ossi, F. Cox, and S. K. Sanyal. 1978. Comparison of pentamidine isethionate and trimethoprimsulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J. Pediatr. 92:285-291.
    • (1978) J. Pediatr. , vol.92 , pp. 285-291
    • Hughes, W.T.1    Feldman, S.2    Chaudhary, S.C.3    Ossi, M.J.4    Cox, F.5    Sanyal, S.K.6
  • 30
    • 0028957202 scopus 로고
    • Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia
    • Hughes, W. T., S. LaFon, J. Scott, and H. Masur. 1995. Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia. J. Infect. Dis. 171:1295-1301.
    • (1995) J. Infect. Dis. , vol.171 , pp. 1295-1301
    • Hughes, W.T.1    LaFon, S.2    Scott, J.3    Masur, H.4
  • 31
    • 0028785517 scopus 로고
    • Monitoring of co-trimoxazole concentrations in serum during treatment of Pneumocystis carinii pneumonia
    • Joos, B., J. Blaser, M. Opravil, J. P. Chave, and R. Luthy. 1995. Monitoring of co-trimoxazole concentrations in serum during treatment of Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 39:2661-2666.
    • (1995) Antimicrob. Agents Chemother. , vol.39 , pp. 2661-2666
    • Joos, B.1    Blaser, J.2    Opravil, M.3    Chave, J.P.4    Luthy, R.5
  • 32
    • 0028009940 scopus 로고
    • Human immunodeficiency virus type I infection of human macrophages modulates the cytokine response to Pneumocystis carinii
    • Kandil, O., J. A. Fishman, H. Koziel, P. Pinkston, R. M. Rose, and H. G. Remold. 1994. Human immunodeficiency virus type I infection of human macrophages modulates the cytokine response to Pneumocystis carinii. Infect. Immun. 62:644-650.
    • (1994) Infect. Immun. , vol.62 , pp. 644-650
    • Kandil, O.1    Fishman, J.A.2    Koziel, H.3    Pinkston, P.4    Rose, R.M.5    Remold, H.G.6
  • 33
    • 0025373992 scopus 로고
    • Clindamycin/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS
    • Kay, R., and R. E. DuBois. 1990. Clindamycin/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS. South. Med. J. 83:403-404.
    • (1990) South. Med. J. , vol.83 , pp. 403-404
    • Kay, R.1    DuBois, R.E.2
  • 35
    • 0022652831 scopus 로고
    • Dapsonetrimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
    • Leoung, G., J. Mills, P. Hopewell, W. Hughes, and C. Wofsy. 1986. Dapsonetrimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann. Intern. Med. 105:45-48.
    • (1986) Ann. Intern. Med. , vol.105 , pp. 45-48
    • Leoung, G.1    Mills, J.2    Hopewell, P.3    Hughes, W.4    Wofsy, C.5
  • 36
    • 0025991669 scopus 로고
    • Effect of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus
    • Levine, S. J., H. Masur, V. J. Gill, I. Feuerstein, A. F. Suffredini, D. Brown, H. C. Lane, R. Yarchoan, J. H. Shelhamer, and F. P. Ognibene. 1991. Effect of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus. Am. Rev. Respir. Dis. 144:760-764.
    • (1991) Am. Rev. Respir. Dis. , vol.144 , pp. 760-764
    • Levine, S.J.1    Masur, H.2    Gill, V.J.3    Feuerstein, I.4    Suffredini, A.F.5    Brown, D.6    Lane, H.C.7    Yarchoan, R.8    Shelhamer, J.H.9    Ognibene, F.P.10
  • 37
    • 0029153566 scopus 로고
    • Steroids do not enhance the risk of developing tuberculosis or other AIDS-related diseases in HIV-infected patients treated for Pneumocystis carinii pneumonia
    • Martos, A., D. Podzamczer, J. Martinez Lacasa, G. Rufi, M. Santin, and F. Gudiol. 1995. Steroids do not enhance the risk of developing tuberculosis or other AIDS-related diseases in HIV-infected patients treated for Pneumocystis carinii pneumonia. AIDS 9:1037-1041.
    • (1995) AIDS , vol.9 , pp. 1037-1041
    • Martos, A.1    Podzamczer, D.2    Martinez Lacasa, J.3    Rufi, G.4    Santin, M.5    Gudiol, F.6
  • 39
    • 0029868424 scopus 로고    scopus 로고
    • Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor
    • Merali, S., and A. Clarkson. 1996. Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor. Antimicrob. Agents Chemother. 40:973-978.
    • (1996) Antimicrob. Agents Chemother. , vol.40 , pp. 973-978
    • Merali, S.1    Clarkson, A.2
  • 40
    • 0025324166 scopus 로고
    • Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)
    • Montaner, J. S. G., L. M. Lawson, N. Levitt, A. Belzberg, M. T. Schecter, and J. Ruedy. 1990. Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 113:14-20.
    • (1990) Ann. Intern. Med. , vol.113 , pp. 14-20
    • Montaner, J.S.G.1    Lawson, L.M.2    Levitt, N.3    Belzberg, A.4    Schecter, M.T.5    Ruedy, J.6
  • 42
    • 0026601038 scopus 로고
    • Salvage therapy with clindamycin/primaquine for Pneumocystis carinii pneumonia
    • Noskin, G., R. Murphy, J. Black, and F. Phair. 1992. Salvage therapy with clindamycin/primaquine for Pneumocystis carinii pneumonia. Clin. Intect. Dis. 14:183-188.
    • (1992) Clin. Intect. Dis. , vol.14 , pp. 183-188
    • Noskin, G.1    Murphy, R.2    Black, J.3    Phair, F.4
  • 43
    • 0031000844 scopus 로고    scopus 로고
    • A 5-year retrospective review of adverse drug reactions and their risk factors in HIV-infected patients who were receiving intravenous therapy for Pneumocystis carinii pneumonia
    • O'Brien, J. G., B. J. Dong, R. L. Coleman, L. Gee, and K. B. Balano. 1997. A 5-year retrospective review of adverse drug reactions and their risk factors in HIV-infected patients who were receiving intravenous therapy for Pneumocystis carinii pneumonia. Clin. Infect. Dis. 24:854-859.
    • (1997) Clin. Infect. Dis. , vol.24 , pp. 854-859
    • O'Brien, J.G.1    Dong, B.J.2    Coleman, R.L.3    Gee, L.4    Balano, K.B.5
  • 44
    • 0029887803 scopus 로고    scopus 로고
    • Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat
    • Phelps, D., T. Umstead, R. Rose, and J. A. Fishman. 1996. Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat. Eur. Respir. J. 9:565-570.
    • (1996) Eur. Respir. J. , vol.9 , pp. 565-570
    • Phelps, D.1    Umstead, T.2    Rose, R.3    Fishman, J.A.4
  • 45
    • 0027491678 scopus 로고
    • 8-Aminoquinolines effective against Pneumocystis carinii in vitro and in vivo
    • Queener, S., M. Bartlett, M. Nasr, and J. Smith. 1993. 8-Aminoquinolines effective against Pneumocystis carinii in vitro and in vivo. Antimicrob. Agents Chemother. 37:2166-2172.
    • (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 2166-2172
    • Queener, S.1    Bartlett, M.2    Nasr, M.3    Smith, J.4
  • 46
    • 0025203459 scopus 로고
    • Extrapulmonary pneumocystosis: The first 50 cases
    • Raviglione, M. C. 1990. Extrapulmonary pneumocystosis: the first 50 cases. Rev. Infect. Dis. 12:1127-1138.
    • (1990) Rev. Infect. Dis. , vol.12 , pp. 1127-1138
    • Raviglione, M.C.1
  • 50
    • 0027932751 scopus 로고
    • Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death
    • Safrin, S., B. Lee, and M. Sande. 1994. Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death. J. Infect. Dis. 170:912-917.
    • (1994) J. Infect. Dis. , vol.170 , pp. 912-917
    • Safrin, S.1    Lee, B.2    Sande, M.3
  • 51
    • 0027971603 scopus 로고
    • Ornithine decarboxylase in Pneumocystis carinii and implications for therapy
    • Saric, M., and A. Clarkson. 1994. Ornithine decarboxylase in Pneumocystis carinii and implications for therapy. Antimicrob. Agents Chemother. 38: 2545-2552.
    • (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 2545-2552
    • Saric, M.1    Clarkson, A.2
  • 52
    • 0028364088 scopus 로고
    • Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: A prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029/031
    • Sattler, F., and ACTG 029/031. 1994. Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029/031. J. Infect. Dis. 170:165-172.
    • (1994) J. Infect. Dis. , vol.170 , pp. 165-172
    • Sattler, F.1
  • 53
    • 0023755203 scopus 로고
    • Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: A prospective, noncrossover study
    • Sattler, F. R., R. Cowan, D. M. Nielsen, and J. Ruskin. 1988. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a prospective, noncrossover study. Ann. Intern. Med. 109:280-287.
    • (1988) Ann. Intern. Med. , vol.109 , pp. 280-287
    • Sattler, F.R.1    Cowan, R.2    Nielsen, D.M.3    Ruskin, J.4
  • 54
    • 0029088797 scopus 로고
    • Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus
    • Simonds, R., W. Hughes, J. Feinberg, and T. Navin. 1995. Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus. Clin. Infect. Dis. 21(Suppl. 1):S44-S48.
    • (1995) Clin. Infect. Dis. , vol.21 , Issue.1 SUPPL.
    • Simonds, R.1    Hughes, W.2    Feinberg, J.3    Navin, T.4
  • 56
    • 0027248912 scopus 로고
    • Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: A randomized, double blind pilot trial
    • Toma, E., S. Fournier, M. Dumont, P. Bolduc, and H. Deschamps. 1993. Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double blind pilot trial. Clin. Infect. Dis. 17:178-184.
    • (1993) Clin. Infect. Dis. , vol.17 , pp. 178-184
    • Toma, E.1    Fournier, S.2    Dumont, M.3    Bolduc, P.4    Deschamps, H.5
  • 57
    • 0024604644 scopus 로고
    • Clindamycin with primaquine for Pneumocystis carinii pneumonia
    • Toma, E., S. Fournier, M. Poisson, R. Morisset, D. Phaneuf, and C. Vega. 1989. Clindamycin with primaquine for Pneumocystis carinii pneumonia. Lancet i:1046-1048.
    • (1989) Lancet , vol.1 , pp. 1046-1048
    • Toma, E.1    Fournier, S.2    Poisson, M.3    Morisset, R.4    Phaneuf, D.5    Vega, C.6
  • 58
    • 0029148566 scopus 로고
    • Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia
    • Vargas, S., W. Hughes, A. Wakefield, and H. Oz. 1995. Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia. J. Infect. Dis. 172:506-510.
    • (1995) J. Infect. Dis. , vol.172 , pp. 506-510
    • Vargas, S.1    Hughes, W.2    Wakefield, A.3    Oz, H.4
  • 61
    • 0029079054 scopus 로고
    • Clinical experience with atovaquone on a treatment investigational new drug protocol for Pneumocystis carinii pneumonia
    • White, A., S. LaFon, M. Rogers, E. Andrews, and N. Brown. 1995. Clinical experience with atovaquone on a treatment investigational new drug protocol for Pneumocystis carinii pneumonia. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 9:280-285.
    • (1995) J. Acquired Immune Defic. Syndr. Hum. Retrovirol. , vol.9 , pp. 280-285
    • White, A.1    LaFon, S.2    Rogers, M.3    Andrews, E.4    Brown, N.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.